Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A gold-standard French-language annotated corpus of oncological entities with ICD-O normalisation.

Scientific data·2026
Same author

Imaging response assessment in metastatic renal cell carcinoma: a radiologist's guide to contemporary therapeutic strategies.

Abdominal radiology (New York)·2026
Same author

Precision medicine's inevitable trajectory toward rare-disease-sized cohorts: implications for machine learning and deep learning.

The Lancet. Digital health·2026
Same author

Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Trends in Pancreatic Cancer Incidence, Mortality and Net Survival: A Population-Based Analysis in Zurich (Switzerland), 1981-2021.

Journal of gastrointestinal cancer·2026
Same author

Impact of the COVID-19 pandemic and its measures on one-year and three-year cancer survival using Swiss cantonal cancer registry data.

Cancer causes & control : CCC·2026

Related Experiment Video

Updated: Sep 3, 2025

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

13.3K

Structure-based prediction of BRAF mutation classes using machine-learning approaches.

Fanny S Krebs1, Christian Britschgi2, Sylvain Pradervand3

  • 1Computer-Aided Molecular Engineering Group, Department of Oncology UNIL-CHUV, University of Lausanne, Epalinges, Switzerland.

Scientific Reports
|July 22, 2022
PubMed
Summary
This summary is machine-generated.

A new machine learning tool predicts the class of BRAF mutations, aiding oncologists in selecting targeted therapies for cancer patients. This computational approach enhances treatment decisions for previously uncharacterized BRAF variants.

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

531

Related Experiment Videos

Last Updated: Sep 3, 2025

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

13.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

531

Area of Science:

  • Oncology
  • Computational Biology
  • Genetics

Background:

  • BRAF kinase alterations activate the MAP kinase pathway, contributing to cancer.
  • BRAF mutations are classified into three groups (I, II, III) based on pathway effects.
  • Classifying BRAF mutations is crucial for tailoring cancer treatments.

Purpose of the Study:

  • To develop an in silico tool for predicting the class of BRAF missense variants.
  • To address the challenge of classifying novel BRAF mutations lacking experimental data.

Main Methods:

  • Utilized machine learning, specifically a logistic regression model.
  • Incorporated structural information and mutation data as features.
  • Focused on predicting classes II and III BRAF mutations.

Main Results:

  • Achieved 90% accuracy in predicting the classes of known BRAF mutations.
  • Developed a fast and efficient predictive tool for BRAF variant classification.

Conclusions:

  • The in silico tool aids oncologists in identifying pathogenic BRAF mutations.
  • Facilitates the selection of the most appropriate targeted therapy for cancer patients.